Skip to content

A randomized controlled study on the effects of Suhexiang aromatherapy intervention on anxiety-agitation and multisymptom management in the anesthesia recovery room of children after general anesthesia

A randomized controlled study on the effects of Suhexiang aromatherapy intervention on anxiety-agitation and multisymptom management in the anesthesia recovery room of children after general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108730
Enrollment
Unknown
Registered
2025-09-04
Start date
2025-09-04
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ENT diseases

Interventions

Experimental group:After surgery, the pediatric patient with ear, nose, and throat was sent to a routine recovery area where a sachet was placed inside the patients mouth and nose
Control group:After surgery, the pediatric patient with ear, nose, and throat was sent to a routine recovery area where an empty sachet was placed inside the patients mouth and nose

Sponsors

Shunyi Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age Range: Children aged 3 to 12 years. 2. Type of Surgery: Patients who undergo general anesthesia for ear, nose, and throat surgeries from August 2024 to August 2025 and enter the PACU. 3. Informed Consent: Signed by the family of the child. (Patients who are 8 years old or older must sign the consent themselves).

Exclusion criteria

Exclusion criteria: 1. Severe mental disorders: Such as schizophrenia, severe depression, and other mental illnesses that affect postoperative recovery. 2. Severe brain diseases: Such as serious head trauma, cerebral palsy, and other brain diseases that affect postoperative monitoring. 3. Deaf-mute patients: Excluded due to the inability to effectively assess postoperative pain and discomfort. 4. Other severe systemic diseases: Such as severe cardiovascular disease, respiratory disease, renal failure, and other systemic diseases that affect postoperative recovery.

Design outcomes

Primary

MeasureTime frame
Number of adverse events;

Secondary

MeasureTime frame
Incidence of postoperative delirium;postoperative pain condition;Incidence of hypoxemia;Awakening time;Postoperative satisfaction of patients and their families;

Countries

China

Contacts

Public ContactWeinan Du

Shunyi Maternal and Child Health Hospital

846369123@qq.com+86 159 1077 7406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026